Platelet activation and the protective effect of aprotinin in hepatolithiasis patients

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 4, 2003, Pages 602-604

  Feng, Wen Ming ^a   Bao, Ying ^a   Fei, Mao Yun ^a   Chen, Qiu Qiang ^a   Yang, Qi ^a   Dai, Chuang ^a  

^a HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Aprotinin; Hepatolithiasis; Platelet membrane glycoproteins

Indexed keywords

APROTININ; CD63 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLYCOPROTEIN IB;

ADULT; AGED; ARTICLE; BILE DUCT STONE; BILIARY TRACT SURGERY; CHOLELITHIASIS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKOCYTE ACTIVATION; LIVER SURGERY; MALE; PATIENT CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; AGED; APROTININ; BLOOD LOSS, SURGICAL; CHOLECYSTECTOMY; CHOLEDOCHOLITHIASIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET COUNT; PREOPERATIVE CARE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0344012935     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Feng WM, Chen QQ, Yang Q, et al. The value of D-dimer in patients with obstructive jaundice. Chin J Hepatobiliary Surg 2001;7:86.
2. Wang YS, Yang J. Clinical researches on changes in amount and aggregation of platelets in patients with hepatolithiasis. Chin J Hpatobiliary Surg 2000;6: 190-191.
3. Kyriss T, Wurst H, Friedel G, et al. Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study. Eur J Cardiothorac Surg 2001;20:38-41.
4. Nomonation and diagnosing criterion of hepatolithiasis diseases. Chin J Surg 1983;6:372-373.
5. Sakaguchi S, Kanda N, Hsu CC, et al. Upid peroxidation formation and membrane damage in endotoxinic poisoned mice. Microbiol Immunol 1981;25:229-232.
6. Ngai KC, Yeuny CY. Additive of tumor necrosis factor and endotoxin on bilirubin cytoxicity. Pediatr Res 1999;1:526-530.
7. Cao B, Fang SQ, Li QQ, et al. The suppressive effect of aprotinin on platelet activation during cardiopulmonary bypass. Chin J Thorac Cardiovasc Surg 1997;13: 25-27.
8. Li TH, Wang ZQ, Sun JL. In vitro effects of aprotinin on human blood platelets. Chin J Anesthesiol 1996; 16:343-345.
9. Huang H, Ding W, Su Z, et al. Mechanism of the preserving effect of aproptinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106:11-18.
10. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993;106:1-4.